Cubist Systematic Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.7M Sell
13,100
-19,000
-59% -$5.51M 0.02% 1167
2025
Q2
$8.96M Buy
+32,100
New +$9.09M 0.04% 668
2025
Q1
Sell
-7,500
Closed -$1.95M 2819
2024
Q4
$1.95M Sell
7,500
-8,400
-53% -$2.49M 0.01% 1370
2024
Q3
$5.12M Buy
15,900
+2,100
+15% +$687K 0.03% 822
2024
Q2
$4.31M Sell
13,800
-26,800
-66% -$7.87M 0.03% 868
2024
Q1
$11.5M Sell
40,600
-9,000
-18% -$2.63M 0.07% 429
2023
Q4
$14.3M Sell
49,600
-4,300
-8% -$1.17M 0.09% 268
2023
Q3
$14.5M Buy
53,900
+4,900
+10% +$1.22M 0.11% 215
2023
Q2
$10.9M Sell
49,000
-27,400
-36% -$6.36M 0.07% 395
2023
Q1
$18.5M Buy
76,400
+23,500
+44% +$5.77M 0.11% 180
2022
Q4
$13.9M Buy
52,900
+14,500
+38% +$3.89M 0.08% 308
2022
Q3
$8.65M Buy
38,400
+17,400
+83% +$4.22M 0.05% 590
2022
Q2
$5.11M Buy
+21,000
New +$5.15M 0.03% 971

Other funds holding AMGN

Cubist Systematic Strategies's AMGN Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of Amgen (AMGN) in Q1 2024, closing a stake of 32,454 shares — an estimated $9.5M sold.

Cubist Systematic Strategies first reported a position in AMGN in Q2 2014 and held it in 37 quarters. The position peaked at $47.7M in Q2 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 32,454 Amgen shares in Q1 2024, an estimated $9.5M.
  • Cubist Systematic Strategies first reported a position in Amgen in Q2 2014 and held it in 37 quarters.
  • Cubist Systematic Strategies's Amgen position peaked at $47.7M in Q2 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.